Search

everythinglearnresearchcommunity

for

Search:↓

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

People with alopecia areata often have lower vitamin D levels than healthy people.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Zinc is important for skin health, and supplements can help treat various skin and hair disorders, but more research is needed for conditions like psoriasis and vitiligo.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Melatonin could be an effective treatment for Alzheimer's Disease and rosacea.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Gut health affects skin diseases, and probiotics might help.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

New genetic discoveries may lead to better treatments for alopecia areata.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Targeting CXCL10 may help treat alopecia areata.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.